DANIELLE BESAND: Open Payments
NPI 1932655479 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$229 in 13 payments from 8 companies in 2025. Trend: 2023 $646 · 2024 $679 · 2025 $229
Food & beverage: $229
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $62 |
| ABBVIE INC. | 3 | $59 |
| Organon LLC | 1 | $25 |
| Novo Nordisk Inc | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: AIRSUPRA, VRAYLAR, NEXPLANON, Wegovy, BREZTRI, REXULTI, UBRELVY, AUSTEDO XR.
Industry payments across MO — which companies pay providers there.
